Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

Cleare AJ, Bearn J, Allain T, McGregor A, Wessely S, Murray RM, O'Keane V.

J Affect Disord. 1995 Aug 18;34(4):283-9.

PMID:
8550954
2.

Thyroid axis activity and serotonin function in major depressive episode.

Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP.

Psychoneuroendocrinology. 1999 Oct;24(7):695-712.

PMID:
10451906
3.

Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.

Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP.

Psychoneuroendocrinology. 2001 Jul;26(5):521-37.

PMID:
11337135
4.
5.

Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.

Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U.

Psychoneuroendocrinology. 2005 Feb;30(2):188-98.

PMID:
15471616
6.

Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.

Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.

J Psychosom Res. 2004 Apr;56(4):419-24.

PMID:
15094026
7.

Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.

Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ.

Psychosom Med. 2006 Jul-Aug;68(4):578-82.

PMID:
16868267
8.

24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.

Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.

Psychosom Med. 2005 May-Jun;67(3):433-40.

PMID:
15911907
10.

Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.

Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.

Psychol Med. 2008 Jul;38(7):963-73. Epub 2007 Sep 6.

PMID:
17803834
11.

Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome.

Yatham LN, Morehouse RL, Chisholm BT, Haase DA, MacDonald DD, Marrie TJ.

Can J Psychiatry. 1995 Mar;40(2):93-6.

PMID:
7788624
12.
13.

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

Bearn J, Allain T, Coskeran P, Munro N, Butler J, McGregor A, Wessely S.

Biol Psychiatry. 1995 Feb 15;37(4):245-52.

PMID:
7711161
14.

Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome.

Moorkens G, Berwaerts J, Wynants H, Abs R.

Clin Endocrinol (Oxf). 2000 Jul;53(1):99-106.

PMID:
10931086
15.

HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.

Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J.

Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(6):781-90.

PMID:
1662403
16.

Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation.

Gaab J, Hüster D, Peisen R, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.

Psychosom Med. 2002 Nov-Dec;64(6):951-62.

PMID:
12461200
17.

Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression.

Cleare AJ, McGregor A, O'Keane V.

Clin Endocrinol (Oxf). 1995 Dec;43(6):713-9.

PMID:
8736274
18.

5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.

Park SB, Williamson DJ, Cowen PJ.

Psychol Med. 1996 Nov;26(6):1191-6.

PMID:
8931165
19.

Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.

Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ.

Neuropsychobiology. 2007;55(2):112-20. Epub 2007 Jun 27. Review.

20.

Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.

Scott LV, Burnett F, Medbak S, Dinan TG.

Psychol Med. 1998 Mar;28(2):285-93.

PMID:
9572086

Supplemental Content

Support Center